Publication & Citation Trends
Publications
0 total
POSTER: AML-442 RAS Mutations Negate the Favorable Impact of NPM1 in Older Patients With Newly-Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA
Cited by 0
Semantic Scholar
POSTER: MPN-569 Apex Part 1: Updated Assessment of Bezuclastinib (CGT9486), a Selective KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis
Cited by 0
Semantic Scholar
POSTER: AML-606 Efficacy and Safety of Olutasidenib Monotherapy in Primary Refractory Acute Myeloid Leukemia: A Post Hoc Analysis of a Phase 2 Study
Cited by 0
Semantic Scholar
AML-732: Ziftomenib Combined With Intensive Induction Chemotherapy (7+3) in Newly Diagnosed NPM1-m or KMT2A-r Acute Myeloid Leukemia (AML): Updated Phase 1a/b Results From KOMET-007
Cited by 4
Semantic Scholar
AML-606: Efficacy and Safety of Olutasidenib Monotherapy in Primary Refractory Acute Myeloid Leukemia: A Post Hoc Analysis of a Phase 2 Study
Cited by 0
Semantic Scholar
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503).
Cited by 0
Semantic Scholar
POSTER: AML-229 Efficacy and Safety of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in the CADENZA Study.
Cited by 0
Semantic Scholar
POSTER: AML-732 Ziftomenib Combined With Intensive Induction Chemotherapy (7+3) in Newly Diagnosed NPM1-m or KMT2A-r Acute Myeloid Leukemia (AML): Updated Phase 1a/b Results From KOMET-007
Cited by 0
Semantic Scholar
Research Topics
Acute Myeloid Leukemia Research
(304)
Multiple Myeloma Research and Treatments
(152)
Chronic Myeloid Leukemia Treatments
(138)
Acute Lymphoblastic Leukemia research
(125)
CAR-T cell therapy research
(96)
Affiliations
Università Cattolica del Sacro Cuore
University of Southern California
West Virginia University
Cedars-Sinai Medical Center
West Los Angeles College